Effects of α1-adrenergic stimulation on normal and hypertrophied mouse hearts. Relation to caveolin-3 expression

Cardiovascular Research

Volumn 63, Issue 3, 2004, Pages 561-572

  Petrashevskaya, Natalia N ^a   Bodi, Ilona ^a   Koch, Sheryl E ^a   Akhter, Shahab A ^a   Schwartz, Arnold ^a  

^a Department of Surgery   (United States)

Author keywords

Adrenergic; Alpha; Calcium; Hypertrophy; Myocardium; Receptors; Signal transduction

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; CAVEOLIN 3; CHELERYTHRINE; G PROTEIN COUPLED RECEPTOR; PROTEIN KINASE C; STAUROSPORINE; ALKALOID; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BENZOPHENANTHRIDINE DERIVATIVE; CALCIUM CHANNEL L TYPE; CAV3 PROTEIN, MOUSE; CAVEOLIN; PHENANTHRIDINE DERIVATIVE; PHENYLEPHRINE;

ADRENERGIC STIMULATION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENE OVEREXPRESSION; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ACTION POTENTIAL; ANIMAL; CARDIOMEGALY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENETICS; HEART CONTRACTION; IMMUNOBLOTTING; MALE; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PERFUSION; PHYSIOLOGY; STIMULATION; TRANSGENIC MOUSE;

ACTION POTENTIALS; ADRENERGIC ALPHA-AGONISTS; ALKALOIDS; ANIMALS; BENZOPHENANTHRIDINES; CALCIUM CHANNELS, L-TYPE; CARDIOMEGALY; CAVEOLIN 3; CAVEOLINS; FEMALE; IMMUNOBLOTTING; MALE; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCARDIUM; PERFUSION; PHENANTHRIDINES; PHENYLEPHRINE; PROTEIN KINASE C; SIGNAL TRANSDUCTION; STAUROSPORINE; STIMULATION, CHEMICAL;

EID: 3242744448     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.01.026     Document Type: Article

References (35)

1. Sussman M.A., Lim H.W., Cude N., et al. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science. 281:1998;1690-1693
2. Mende U., Kagen A., Cohen A., et al. Transient cardiac expression of constitutively active Gαq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc. Natl. Acad. Sci. U. S. A. 95:1998;13893-13898
3. Fiedler B., Lohmann S.M., Smolenski A., et al. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Proc. Natl. Acad. Sci. U. S. A. 99:2002;11363-11368
4. Kato T., Sano M., Miyoshi S., et al. Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats. Circ. Res. 87:2000;937-945
5. 2+-activated but not G-protein mediated inositol phosphate responses in rat neonatal cardiomyocytes involve inositol 1,4,5-trisphosphate generation. J. Biol. Chem. 275:2000;10845-10850
6. 2+-dependent transgenic model of cardiac hypertrophy. A role for protein kinase Cα Circulation. 103:2001;140-147
7. Rubin V., Xu X., Steinberg S., et al. Activated protein kinase C isoforms target to cardiomyocyte caveolae. Circ. Res. 84:1999;980-988
8. Hare J., Lofthouse R., Juang G., et al. Contribution of caveolin protein abundance to augment nitric oxide signaling in conscious dogs with pacing-induced heart failure. Circ. Res. 86:2000;1085-1092
9. 1-adrenergic signal within calveolae: caveolin expression and the development of cardiac hypertrophy. Cardiovasc. Res. 51:2001;709-716
10. 1-subunit of the L-type voltage-dependent calcium channel in transgenic mice. J. Biol. Chem. 274:1999;21503-21506
11. i restores uncoupled β-adrenergic signaling in isolated perfused transgenic mouse heart. Circ. Res. 88:2001;9-11
12. Petrashevskaya N., Bodi I., Rubio M., Molkentin J., Schwartz A. Cardiac function and electrical remodeling of the calcineurin-overexpressed transgenic mouse. Cardiovasc. Res. 54:2002;117-132
13. Karmazyn M., Watson J., Moffat M. Mechanism for cardiac depression induced by phorbol myristate acetate in working rat heart. Br. J. Pharmacol. 1009:1990;826-830
14. Tanaka H., Manita S., Matsuda T., et al. Sustained negative inotropism mediated by α-adrenoceptors in adult mouse myocardia: developmental conversion from positive response in the neonate. Br. J. Pharmacol. 114:1995;673-677
15. 2+ exchange in mouse ventricle. Am. J. Physiol. 280:2001;H132-H141
16. 1-adrenergic-mediated contraction and translocation of PKC in senescent rat heart. Am. J. Physiol. 281:2001;H581-H589
17. 1-adrenoceptors mediate positive inotropic effect and changes in phosphatidylinositol metabolisms: species differences in receptor distribution and the intracellular coupling process in mammalian ventricular myocardium. Circ. Res. 68:1991;1179-1190
18. 2+ mediated through α- and β-adrenoceptors. Circ. Res. 62:1988;247-265
19. Uehata M., Ishizaki T., Satoh H., et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 389:1997;990-994
20. 1-AR- induced positive inotropic response in heart is dependent on myosin light chain phosphorylation. Am. J. Physiol. 283:2002;H1471-H1480I
21. Venema R.C., Kuo J.F. Protein kinase C-mediated phosphorylation of troponin I and C-protein in isolated myocardial cells is associated with inhibition of myofibrillar actomyosin MgATPase. J. Biol. Chem. 268:1993;2705-27711
22. 2+ sensitivity in cardiotrabeculae. Biochemistry. 34:1995;2309-2316
23. Montgomery D.E., Chandra M., Huang Q., et al. Transgenic incorporation of skeletal TnT into cardiac myofilaments blunts PKC-mediated depression of force. Am. J. Physiol. 280:2001;H1011-H1018
24. 2+-stimulated MgATPase of reconstituted actomyosin S-1. J. Biol. Chem. 270:1995;25445-25454
25. 1A- adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy. Circ. Res. 89:2001;343-350
26. 1B-adrenergic receptors after pressure overload in mouse hearts. Am. J. Physiol. 279:2000;H1079-H1086
27. 1C. J. Biol. Chem. 271:1996;5839-5843
28. Mittmann C., Chung C.H., Hoppner G., et al. Expression of ten RGS proteins in human myocardium: functional characterization an upregulation of RGS4 in heart failure. Cardiovasc. Res. 55:2002;778-786
29. Wieland T., Mittman C. Regulators of G-protein signaling: multifunctional proteins with impact on signaling in the cardiovascular system. Pharmacol. Ther. 97:2003;95-115
30. + exchange is impaired in cardiac hypertrophy. J. Clin. Invest. 99:1997;125-135
31. Schunkert H., Weinberg E.O., Bruckschlegel G., et al. Alteration in growth responses in established cardiac pressure overload hypertrophy in rats with aortic banding. J. Clin. Invest. 96:1995;2768-2774
32. Jalili T., Takeishi Y., Song G., et al. PKC translocation without changes in Gαq and PLC-β protein abundance in cardiac hypertrophy and failure. Am. J. Physiol. 277:1999;H2298-H2304
33. Couet J., Sargiacomo M., Lisanti M.P. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolins binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 272:1997;30429-30438
34. Woodman S.E., Park D.S., Cohen A.W., et al. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J. Biol. Chem. 277:2002;38988-38997
35. Petrashevskaya N., Bodi I., Varadi G., Molkentin J., Schwartz A. Decreased eNOS expression in murine transgenic models of cardiac hypertrophy. Biophys. J. 82:2002;602a. [Abstract]